JOURNAL ARTICLE
Morning Sickness.
Published In: Pulse International, 2026, v. 27, n. 5. P. N.PAG 1 of 2
Database: Academic Search Ultimate 2 of 2
Abstract
The article focuses on the historical use and risks of thalidomide, a drug once widely prescribed in the 1950s for morning sickness in pregnant women but later banned in 1960-61 due to causing limb deformities in newborns. It highlights a recent incident in the U.S. where an AI search engine incorrectly recommended thalidomide for morning sickness, underscoring the importance of consulting trusted healthcare providers and verifying medical information. The article also explains that morning sickness, characterized by nausea and vomiting during pregnancy, is generally mild and managed with vitamin B6, antihistamines, dietary adjustments, and rest, while severe cases require medical attention. Despite its ban for pregnancy-related use, thalidomide remains approved for treating certain cancers such as multiple myeloma. [Extracted from the article]
Additional Information
- Source:Pulse International. 2026/03, Vol. 27, Issue 5, pN.PAG
- Document Type:Article
- Subject Area:Health and Medicine
- Publication Date:2026
- ISSN:1682-0274
- Accession Number:192316666
- Copyright Statement:Copyright of Pulse International is the property of Knowledge Bylanes and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.